BioDelivery Sciences International, Inc. (BDSI) Financial Statements (2026 and earlier)
Company Profile
| Business Address |
4131 PARKLAKE AVENUE RALEIGH, NC 27612 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
| 12/31/2021 Q4 | 9/30/2021 Q3 | 6/30/2021 Q2 | 3/31/2021 Q1 | 12/31/2020 Q4 | 9/30/2020 Q3 | 6/30/2020 Q2 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 100,710 | 119,853 | 116,436 | 111,584 | 100,177 | 91,009 | |||
| Cash and cash equivalent | 100,710 | 119,853 | 116,436 | 111,584 | 100,177 | 91,009 | |||
| Receivables | 57,572 | 52,872 | 48,294 | 48,150 | 43,830 | 48,126 | |||
| Inventory, net of allowances, customer advances and progress billings | 23,075 | 18,659 | 16,968 | 17,443 | 18,887 | 17,774 | |||
| Inventory | 23,075 | 18,659 | 16,968 | 17,443 | 18,887 | 17,774 | |||
| Other undisclosed current assets | 6,904 | 4,680 | 4,449 | 5,208 | 5,754 | 2,099 | |||
| Total current assets: | 188,261 | 196,064 | 186,147 | 182,385 | 168,648 | 159,008 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 471 | ||||||||
| Intangible asset, including goodwill, after accumulated amortization | 66,284 | 52,623 | 54,357 | 56,091 | 57,824 | 59,557 | |||
| Goodwill | 2,715 | 2,715 | 2,715 | 2,715 | 2,715 | 2,715 | |||
| Intangible asset, excluding goodwill, after accumulated amortization | 63,569 | 49,908 | 51,642 | 53,376 | 55,109 | 56,842 | |||
| Deferred income tax assets | |||||||||
| Other undisclosed noncurrent assets | 1,525 | 1,640 | 1,626 | 947 | 1,485 | 1,508 | |||
| Total noncurrent assets: | 67,809 | 54,263 | 55,983 | 57,509 | 59,309 | 61,065 | |||
| TOTAL ASSETS: | 256,070 | 250,327 | 242,130 | 239,894 | 227,957 | 220,073 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 74,580 | 57,752 | 54,584 | 52,995 | 53,409 | 56,646 | |||
| Taxes payable | 583 | (22) | 1,026 | ||||||
| Employee-related liabilities | 6,832 | 6,115 | 4,796 | 5,488 | 5,603 | 4,557 | |||
| Accounts payable | 7,033 | 4,073 | 5,308 | 4,213 | 8,244 | 13,289 | |||
| Accrued liabilities | 41,010 | 38,427 | 35,538 | 36,228 | 29,799 | 29,918 | |||
| Other undisclosed accounts payable and accrued liabilities | 19,122 | 9,159 | 7,916 | 7,066 | 9,763 | 8,882 | |||
| Debt | 3,077 | 6,154 | |||||||
| Total current liabilities: | 77,657 | 63,906 | 54,584 | 52,995 | 53,409 | 56,646 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 55,638 | 72,472 | 78,538 | 78,452 | 78,363 | 78,274 | |||
| Long-term debt, excluding current maturities | 55,638 | 72,472 | 78,538 | 78,452 | 78,363 | 78,274 | |||
| Liabilities, other than long-term debt | 31 | 154 | 213 | 300 | 383 | ||||
| Other liabilities | 31 | 154 | 213 | 300 | 383 | ||||
| Total noncurrent liabilities: | 55,638 | 72,503 | 78,692 | 78,665 | 78,663 | 78,657 | |||
| Total liabilities: | 133,295 | 136,409 | 133,276 | 131,660 | 132,072 | 135,303 | |||
| Equity | |||||||||
| Equity, attributable to parent | 122,775 | 113,918 | 108,854 | 108,234 | 95,885 | 84,770 | |||
| Common stock | 104 | 104 | 104 | 104 | 100 | 99 | |||
| Treasury stock, value | (12,155) | (12,155) | (6,399) | (252) | (47) | (47) | |||
| Additional paid in capital | 454,738 | 452,550 | 450,794 | 449,264 | 446,910 | 445,180 | |||
| Accumulated deficit | (319,912) | (326,581) | (335,645) | (340,882) | (351,078) | (360,462) | |||
| Total equity: | 122,775 | 113,918 | 108,854 | 108,234 | 95,885 | 84,770 | |||
| TOTAL LIABILITIES AND EQUITY: | 256,070 | 250,327 | 242,130 | 239,894 | 227,957 | 220,073 | |||
Income Statement (P&L) ($ in thousands)Annual | Quarterly
| 12/31/2021 Q4 | 9/30/2021 Q3 | 6/30/2021 Q2 | 3/31/2021 Q1 | 12/31/2020 Q4 | 9/30/2020 Q3 | 6/30/2020 Q2 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 41,092 | 41,439 | 41,020 | 42,167 | 39,443 | 36,582 | ||
| Cost of revenue (Cost of Product and Service Sold) | (6,365) | (4,284) | (5,821) | (8,294) | (5,376) | (5,435) | ||
| Gross profit: | 34,727 | 37,155 | 35,199 | 33,873 | 34,067 | 31,147 | ||
| Operating expenses | (25,468) | (25,779) | (27,761) | (21,419) | (22,461) | (28,211) | ||
| Operating income: | 9,259 | 11,376 | 7,438 | 12,454 | 11,606 | 2,936 | ||
| Nonoperating income (expense) (Other Nonoperating Income (Expense)) | (1) | (9) | (2) | 8 | ||||
| Interest and debt expense | (1,984) | (1,999) | (1,979) | (2,010) | (1,693) | |||
| Other undisclosed income from continuing operations before equity method investments, income taxes | 4,997 | |||||||
| Income from continuing operations before equity method investments, income taxes: | 7,275 | 9,376 | 5,459 | 17,442 | 9,594 | 1,251 | ||
| Other undisclosed loss from continuing operations before income taxes | (7,013) | |||||||
| Income from continuing operations before income taxes: | 7,275 | 9,376 | 5,459 | 10,429 | 9,594 | 1,251 | ||
| Income tax expense (benefit) | (606) | (312) | (222) | (233) | (211) | (86) | ||
| Income from continuing operations: | 6,669 | 9,064 | 5,237 | 10,196 | 9,383 | 1,165 | ||
| Income before gain (loss) on sale of properties: | 6,669 | 9,064 | 5,237 | 10,196 | 9,383 | 1,165 | ||
| Net income: | 6,669 | 9,064 | 5,237 | 10,196 | 9,383 | 1,165 | ||
| Other undisclosed net income attributable to parent | 1 | |||||||
| Net income attributable to parent: | 6,669 | 9,064 | 5,237 | 10,196 | 9,384 | 1,165 | ||
| Other undisclosed net loss available to common stockholders, basic | (1) | |||||||
| Net income available to common stockholders, diluted: | 6,669 | 9,064 | 5,237 | 10,196 | 9,383 | 1,165 | ||
Comprehensive Income ($ in thousands)Annual | Quarterly
| 12/31/2021 Q4 | 9/30/2021 Q3 | 6/30/2021 Q2 | 3/31/2021 Q1 | 12/31/2020 Q4 | 9/30/2020 Q3 | 6/30/2020 Q2 | ||
|---|---|---|---|---|---|---|---|---|
| Net income: | 6,669 | 9,064 | 5,237 | 10,196 | 9,383 | 1,165 | ||
| Comprehensive income, net of tax, attributable to parent: | 6,669 | 9,064 | 5,237 | 10,196 | 9,383 | 1,165 | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.